Individual Therapeutic DAS28-dcrit Responses Differentiate Between Effectiveness of Rheumatoid Arthritis Therapies and Reflect Patient-Reported Outcomes: Retrospective Analysis of DAS28 Responses in Comparative Tocilizumab Studies

Rheumatology International - Germany
doi 10.1007/s00296-020-04514-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

RMD Open
RheumatologyAllergyImmunology
2017English

Interpretation of DAS28 and Its Components in the Assessment of Inflammatory and Non-Inflammatory Aspects of Rheumatoid Arthritis

BMC Rheumatology
Rheumatology
2018English

Time to Modify the DAS28 to Make It Fit for Purpose(s) in Rheumatoid Arthritis?

Expert Review of Clinical Immunology
AllergyImmunology
2019English

Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Relationship Between Time-Integrated Disease Activity Estimated by DAS28-CRP and Radiographic Progression of Anatomical Damage in Patients With Early Rheumatoid Arthritis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2011English

Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis

Current Oral Health Reports
2014English

Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy